Welcome to the first issue of our e-newsletter

Dear colleagues,

We are writing to you with the latest news from the RADAR-CNS (Remote assessment of disease and relapse – Central Nervous System) programme. After many months of technical development, user acceptability studies and protocol development the RADAR CNS programme is now in...

Image: the RADAR-CNS team (June 2016)

We’re delighted to be under way with the in-hospital epilepsy study and main depression component of the study. The Multiple sclerosis (MS) component is ready to start once we are confident that the platform is working as planned.  We hope to welcome many more participants across the UK, Italy, The Netherlands, Spain, Denmark and Germany in the coming months.

This year we held our successful first RADAR-CNS annual consortium meeting in Barcelona, Spain, in June; all three disorders got their studies approved through ethics committees; project members have discussed our work to date at conferences across the world and to members of the European Parliament; and colleagues across the programme have worked exceptionally hard to get us to this point.

There is lots to look forward to in 2018 including our second RADAR-CNS annual consortium meeting taking place in April 2018 in Prague, Czech Republic.

We wish everyone a very Merry Christmas and a fantastic 2018,

Matthew Hotopf, King's College London
Vaibhav Narayan, Janssen Pharmaceutica NV
RADAR-CNS Project Co-Leads


RADAR-CNS depressive disorder study recruits first participants

EFPIA presentation to the European Parliament

Digital Technology in Practice

Click here to view the newsletter in your browser